Estonia - estone - Ravimiamet

inresa arzneimittel gmbh - tiopentaal - süstelahuse pulber - 1000mg 25tk; 1000mg 10tk

Estonia - estone - Ravimiamet

inresa arzneimittel gmbh - ketamiin - süstelahus - 50mg 1ml 10ml 5tk

Estonia - estone - Ravimiamet

inresa - naloksoon - süstelahus - 0,4mg 1ml 1ml 10tk

Estonia - estone - Ravimiamet

inresa arzneimittel gmbh - erütromütsiin - infusioonilahuse pulber - 1g 10tk

Estonia - estone - Ravimiamet

inresa arzneimittel gmbh - vekurooniumbromiid - süstelahuse pulber - 10mg 10tk

Estonia - estone - Ecolab

ecolab deutschland gmbh -

Estonia - estone - Ravimiamet

g.l. pharma gmbh - esketamiin - süste-/infusioonilahus - 25mg 1ml 2ml 10tk

Unione Europea - estone - EMA (European Medicines Agency)

astellas pharma europe b.v. - ensalutamiid - eesnäärmevähk - endokriinset ravi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Estonia - estone - Ravimiamet

sandoz pharmaceuticals d.d. - ensalutamiid - õhukese polümeerikattega tablett - 80mg 14tk

Estonia - estone - Ravimiamet

sandoz pharmaceuticals d.d. - ensalutamiid - õhukese polümeerikattega tablett - 40mg 112tk